DK Medical Solutions Co. Ltd made a contract with Seoul National University as consortium with Toshiba 

to provide the ‘Heavy Ion Therapy System. 

Introduced the world’s best technology ‘Heavy Ion Therapy System’ in Korea. 

- DK Medical Solutions – Toshiba consortium and Seoul National University sign agreement 

- Targeting intractable cancer

 DK Medical Solutions announced its recent partnership with Seoul National University for Heavy Ion Therapy System to be used to treat manufactured by the Japanese company Toshiba. The consortium between Korea’s DK Medical Solution and Toshiba will be set up at the Seoul National University Hospital's Gijang Heavy Ion Therapy Center in Gijang-gun, Busan, and officially begin patient treatment in 2025. 

 Heavy Ion Therapy System utilizes carbon ion beams that are accelerated to almost match the speed of light and delivered to cancer cells. Only 12 centers in the world are currently equipped with the technology. By only delivering the radiation beam to the cancer cells, normal cells are kept, significantly reducing the risk of adverse effects.

 Heavy Ion Therapy System is effective for the major solid cancers, including lung cancer, liver cancer, pancreatic cancer, recurrent rectal cancer and osteosarcoma. In fact, the five-year survival rate of lung cancer nearly tripled from 15.5 percent to 39.8 percent with the Heavy Ion Therapy System. Whereas radiation therapy requires the patient to visit the hospital at least a dozen times over the course of two to three weeks, Heavy Ion Therapy System reduces the number of visits to fewer than a dozen.

 Gijang Heavy Ion Therapy Center will be equipped with a rotating gantry treatment room and a fixed beam treatment room, where Toshiba's latest technology will be implemented to enable conducting tests with high radiation doses and extensive beams.

 DK Medical Solutions delivered its statement: "Congratulations to Seoul National University on introducing the world's most advanced heavy ion therapy device to its Gijang Heavy Ion Therapy Center. We will do our best to ensure that the “miracle” treatment device maintains the optimal performance level at all times and continue our efforts to implement newest cancer treatment innovations to assist in furthering ion radiation treatment and research.”